Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Ráidu: | Бюллетень сибирской медицины |
| Fáttát: | |
| Liŋkkat: | https://bulletin.ssmu.ru/jour/article/view/1618 |